Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 215-170-3 | CAS number: 1309-42-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 2010-03-30 to 2010-06-15
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Version / remarks:
- adopted 21 July 1997
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.10 (Mutagenicity - In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- Magnesium hydroxide
- EC Number:
- 215-170-3
- EC Name:
- Magnesium hydroxide
- Cas Number:
- 1309-42-8
- Molecular formula:
- H2MgO2
- IUPAC Name:
- magnesium dihydroxide
Constituent 1
- Specific details on test material used for the study:
- - Name of the test material used in the report: Magnesium hydroxide
- Appearance: white powder
- Batch No.: 20BR0026
- Purity: 99.90%
- Storage: at room temperature in the dark
- Expiry date: 2012-01-31
Method
- Target gene:
- Not applicable
Species / strain
- Species / strain / cell type:
- lymphocytes: Primary culture obtained from whole blood of healthy male subjects
- Details on mammalian cell type (if applicable):
- Not a cell line
- Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9-mix
- Test concentrations with justification for top dose:
- Dose range-finding/first cytogenetic assay concentrations: 0.3, 1, 3, 10, 33 and 100 ug/ml.
Second cytogenetic assay concentrations: 3, 10 and 33 ug/ml. - Vehicle / solvent:
- Magnesium hydroxide was suspended in DMSO of spectroscopic quality at concentrations of 0.3 mg/ml and above. The solution was ultrasonicated to achieve a homogeneous suspension. At concentrations of 0.1 mg/ml and below the test substance was dissolved in DMSO. Magnesium hydroxide concentrations were used within 2.5 hours after preparation. The final concentration of the solvent in the culture medium was 1.0 % (v/v).
Controls
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Remarks:
- Migrated to IUCLID6: Mitomycin C (MMC-C) was used as a positive control in cultures without metabolic activation. Cyclophosphamide (CP) was used as a positive control in cultures with metabolic activation.
- Details on test system and experimental conditions:
- TEST SYSTEM: Cultured peripheral human lymphocytes (primary culture)
METHOD OF APPLICATION: The test substance was dissolved in DMSO and added to lymphocytes within 2.5 hours of preparation. The final concentration of DMSO in the culture medium was 1.0 % (v/v)
DURATION
- Preincubation period: Lymphocytes were cultured for 48 h prior to the addition of magnesium hydroxide.
- Exposure duration: In the first cytogenetic assay, lymphocytes were exposed to magnesium hydroxide for 3 h, 24 h and 48 h in the absence of S9-mix, or 3 h in the presence of S9-mix. In the second cytogenetic assay, lymphocytes were exposed to magnesium hydroxide for 24 h and 48 h in the absence of S9-mix or for 3 h in the presence of S9-mix.
- Fixation time: After 3 hours of exposure cells were washed twice in HBSS and incubated for another 20-22 hours for fixation (24 hour exposure time). Cells that were exposed for 24 and 48 hours in the absence of S9-mix were not rinsed after exposure and were fixed immediately (24 and 48 hour fixation time, respectively).
SPINDLE INHIBITOR (cytogenetic assays): Colchicine
During the last 2.5 - 3 h of the culture period, cell division was arrested by the addition of the spindle inhibitor colchicine (0.5 ug/ml medium). Thereafter the cell cultures were centrifuged for 5 min at 1300 rpm and the supernatant was removed. Cells in the remaining cell pellet were swollen by a 5 min treatment with hypotonic 0.56 % (w/v) potassium chloride solution at 37 °C. After hypotonic treatment, cells were fixed with 3 changes of methanol:acetic acid fixative (3:1).
STAIN (for cytogenetic assays): Slides were stained for 10-30 min with 5 % (v/v) Giemsa solution in tap water.
NUMBER OF REPLICATIONS: In the first cytogenetic assay, the lymphocytes were cultured in duplicate at the 3 hour exposure period only. In the second cytogenetic assay, all cultures were performed in duplicate.
NUMBER OF CELLS EVALUATED: 100 metaphase chromosome spreads per culture were examined by light microscopy for chromosome aberrations. All slides were randomly coded before examination of chromosome aberrations to prevent bias.
DETERMINATION OF CYTOTOXICITY
Mitotic index
OTHER EXAMINATIONS:
- Determination of polyploidy: Yes
- Determination of endoreplication: Yes - Evaluation criteria:
- A test substance was considered positive (clastogenic) in the chromosome aberration test if:
a) It induced a dose-related statistically significant increase in the number of cells with chromosome aberrations.
b) A statistically significant and biologically relevant increase in the frequencies of the number of cells with chromosome aberrations was observed in the absence of a clear dose-response relationship.
A test substance was considered negative (non-clastogenic) if none of the tested concentrations induced a statistically significant increase in the number of cells with chromosome aberrations. - Statistics:
- The incidence of aberrant cells for each exposure group outside the laboratory historical control data range was compared to that of the solvent control using Chi-square statistics.
Results and discussion
Test results
- Species / strain:
- lymphocytes: human
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- Please see section "Any other information on results incl. tables"
Any other information on results incl. tables
At concentrations of 33 µg/ml and above, magnesium hydroxide precipitated in the culture medium. Thus, magnesium hydroxide was tested up to precipitating concentrations only in the second cytogenetic assay. Magnesium hydroxide was tested beyond the limit of solubility in the first cytogenetic assay in order to obtain adequate toxicity data.
The data presented in Tables 1 and 4 shows that magnesium hydroxide had little or no effect on the mitotic index of lymphocyte cultures. The scores for the number of aberrant cells (gaps included and excluded) and the number of aberrant cells are presented in Tables 2, 3 and 5-7. Both in the presence and absence of S9-mix, magnesium hydroxide did not induce a statistically significant or biologically relevant increase in the number of cells with chromosome aberrations. In addition, magnesium hydroxide did not increase the number of polyploidy cells and cells with endoreduplicated chromosomes.
The number of cells with chromosome aberrations, polyploidy cells and cells with endoreduplicated chromosomes found in the solvent control cultures was within the laboratory historical control data range. In addition, the positive control chemicals both produced statistically significant increases in the frequency of aberrant cells. It was thus concluded that the test conditions were adequate and that the metabolic activation system functioned properly.
Please see the attached background material for a list of tables.
Applicant's summary and conclusion
- Conclusions:
- Based on the results of this study, it is concluded that magnesium hydroxide is not clastogenic in human lymphocytes under the conditions described in this report.
- Executive summary:
In a mammalian cell cytogenetics assay conducted according to OECD 473, peripheral human lymphocytes were exposed to magnesium hydroxide (99.9% purity) dissolved in DMSO.
In the first cytogenetic assay, magnesium hydroxide was tested at up to 33 µg/mL for a 3-hour exposure time with a 24-hour fixation time in the presence and absence of S9 -mix. In a second cytogenetic assay, magnesium hydroxide was tested at up to 33 µg/mL for a 24- and 48-hour continuous exposure time with a 24- and 48-hour fixation time in the absence of S9 -mix. In the presence of S9 -mix, magnesium hydroxide was also tested at up to 33 µg/mL for a 3-hour exposure time with a 48-hour fixation time.
Magnesium hydroxide had little or no effect on the mitotic index of lymphocyte cultures, a measure of cytotoxicity. There was no evidence of chromosome aberration induced over background in both experiments.
This study is classified as acceptable. This study satisfies the requirement for Test Guideline OECD 473 for in vitro cytogenetic mutagenicity data.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.